Wegovy 1 mg (Needles included)

Wegovy Semaglutide A Doctor Guided Weight Management Treatment Wegovy contains semaglutide, a prescription medication used as part of a medically supervised weight management program. Wegovy is a GLP 1 receptor agonist that can help regulate appetite, reduce food intake and support weight loss. It may also help you feel fuller for longer by slowing the rate at which food leaves the stomach. How It Works Wegovy may help with weight management by: Helping reduce appetite and food cravings Increasing feelings of fullness Supporting reduced food intake Helping regulate blood sugar levels Slowing the rate at which food leaves the stomach How Is Wegovy Taken Wegovy is administered as a once weekly subcutaneous injection. Treatment is started at a prescribed dose and the dose may be gradually increased by the treating physician based on your medical condition, response to treatment and tolerability. Do not change the dose or treatment schedule without consulting your doctor. Available Strengths Wegovy is available in different strengths as part of dose escalation and maintenance treatment, including 0.5 mg, 1 mg, 1.7 mg and 2.4 mg presentations registered by the Saudi Food and Drug Authority SFDA. The strength prescribed will depend on your individual treatment plan and medical assessment. Important: Product images are for illustrative purposes only. Images showing multiple strengths or products do not mean that all strengths or products shown are included in your order. Only the strength prescribed and selected for your order will be supplied. Medical Consultation and Prescription Wegovy is a prescription medication. If you do not have a valid prescription, you will be referred to a licensed healthcare provider for a medical assessment to determine whether the treatment is medically appropriate for you. The medical assessment, diagnosis, treatment decision and prescription are carried out by licensed healthcare professionals affiliated with the relevant licensed healthcare provider. Valeo Health does not itself determine medical eligibility or issue prescriptions. Who May Be Eligible According to the SFDA approved indication, Wegovy may be used as an adjunct to a reduced calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with: BMI 30 kg per m2 or higher obesity BMI 27 kg per m2 to less than 30 kg per m2 overweight in the presence of at least one weight related comorbidity, such as dysglycaemia, hypertension, dyslipidaemia, obstructive sleep apnoea or cardiovascular disease. Final eligibility and suitability for treatment are determined by a licensed healthcare professional. Pharmacy Dispensing Once a valid prescription has been issued and all applicable dispensing requirements have been satisfied, the medication is dispensed through a licensed pharmacy. If a prescription is not issued or the required dispensing conditions are not met, the medication order will not be completed, and the order and any amounts paid will be handled according to the applicable procedures. Important Safety Information Wegovy is a prescription medicine and should be used only under the supervision of a qualified healthcare professional. Before starting treatment, inform your doctor about your medical history, current medications, allergies and any other relevant health conditions. Possible side effects may include gastrointestinal symptoms such as nausea, diarrhea, vomiting, constipation and abdominal discomfort. GLP 1 receptor agonists, including semaglutide, have an identified risk of acute pancreatitis. The SFDA has specifically reiterated this safety information for Wegovy and other GLP 1 receptor agonists. Do not start, stop or change Wegovy treatment without medical advice. Service and Healthcare Partners Platform Valeo Health Information Technologies One Person Limited Liability Company Pharmacy Partner Nokhbat Al Amaken Medical Company License No 4030412961 Teleconsultation Partner Al Riayah Al Shafiyah Medical Company CURA License No 1400005491 Clinic Partner Al Musan Al Tabiya Ltd Company License No 7025162988 Role of Valeo Health Valeo Health operates as an electronic technology and marketing platform that displays and markets services and programs and connects customers with licensed service providers in the Kingdom of Saudi Arabia. Its role includes operating the electronic platform, managing the customer experience, conducting electronic marketing activities, receiving customer orders and managing the technical and commercial aspects associated with the platform. Valeo Health does not itself engage in medical or clinical practice, diagnose medical conditions, issue medical prescriptions or directly dispense prescription medicines. Healthcare services are performed by the relevant licensed healthcare providers according to the scope of their licenses. Disclaimer Wegovy is a prescription medication. Eligibility for treatment, dosage, duration of treatment and suitability are determined by a licensed healthcare professional. This product listing does not constitute medical advice, diagnosis or a prescription. Product availability is subject to prescription, medical eligibility and applicable dispensing requirements.